L-beta-threo-benzyl-aspartate: structure in first source [MeSH]
ID Source | ID |
---|---|
PubMed CID | 11622683 |
CHEMBL ID | 458273 |
SCHEMBL ID | 14498029 |
MeSH ID | M0495549 |
Synonym |
---|
NCGC00186040-01 |
CHEMBL458273 , |
HMS3263L05 |
l-beta-threo-benzyl-aspartate |
LP01172 |
gtpl4625 |
(2s,3s)-2-amino-3-(phenylmethyl)butanedioic acid |
l-beta-ba |
CCG-222476 |
SCHEMBL14498029 |
tox21_501172 |
NCGC00261857-01 |
bdbm50197049 |
Q27079166 |
871123-98-7 |
(2s,3s)-2-amino-3-benzylbutanedioic acid |
DTXSID501017554 |
SDCCGSBI-0633800.P001 |
NCGC00186040-02 |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) |
---|---|---|---|---|
dopamine D1 receptor | Homo sapiens (human) | Potency | 29.0929 | AID624455 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 10.5909 | AID1224820 |
arylsulfatase A | Homo sapiens (human) | Potency | 0.0379 | AID720538 |
euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 7.0795 | AID504332 |
chromobox protein homolog 1 | Homo sapiens (human) | Potency | 5.0119 | AID488953 |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) |
---|---|---|---|---|
Excitatory amino acid transporter 1 | Homo sapiens (human) | IC50 | 36.9954 | AID1321948; AID1725868 |
Excitatory amino acid transporter 2 | Homo sapiens (human) | IC50 | 31.5526 | AID1321949; AID1725869 |
Excitatory amino acid transporter 3 | Homo sapiens (human) | IC50 | 7.5883 | AID1321950; AID1725870 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID365686 | Selectivity for human EAAT3 over human EAAT2 expressed in mouse C17.2 cells | 2008 | Bioorganic & medicinal chemistry, Aug-15, Volume: 16, Issue:16 ISSN: 1464-3391 | Synthesis and preliminary pharmacological evaluation of novel derivatives of L-beta-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3. |
AID1321950 | Inhibition of [3H]-D-Asp uptake at human EAAT3 expressed in HEK293 cells measured after 3 mins by TopCount method | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19 ISSN: 1520-4804 | β-Sulfonamido Functionalized Aspartate Analogues as Excitatory Amino Acid Transporter Inhibitors: Distinct Subtype Selectivity Profiles Arising from Subtle Structural Differences. |
AID365685 | Selectivity for human EAAT3 over human EAAT1 expressed in mouse C17.2 cells | 2008 | Bioorganic & medicinal chemistry, Aug-15, Volume: 16, Issue:16 ISSN: 1464-3391 | Synthesis and preliminary pharmacological evaluation of novel derivatives of L-beta-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3. |
AID1725868 | Inhibition of human EAAT1 transfected in mouse C17.2 cells assessed as inhibition of [3H]-D-aspartate uptake incubated for 5 mins by liquid scintillation counting analysis | 2020 | ACS medicinal chemistry letters, Nov-12, Volume: 11, Issue:11 ISSN: 1948-5875 | β-Indolyloxy Functionalized Aspartate Analogs as Inhibitors of the Excitatory Amino Acid Transporters (EAATs). |
AID1725871 | Selectivity index, ratio of IC50 for human EAAT1 transfected in mouse C17.2 cells to IC50 for human EAAT3 transfected in mouse C17.2 cells incubated for 5 mins by [3H]-D-aspartate uptake assay | 2020 | ACS medicinal chemistry letters, Nov-12, Volume: 11, Issue:11 ISSN: 1948-5875 | β-Indolyloxy Functionalized Aspartate Analogs as Inhibitors of the Excitatory Amino Acid Transporters (EAATs). |
AID365684 | Inhibition of [3H]D-aspartate uptake at human EAAT3 expressed in mouse C17.2 cells at 100 uM relative to control | 2008 | Bioorganic & medicinal chemistry, Aug-15, Volume: 16, Issue:16 ISSN: 1464-3391 | Synthesis and preliminary pharmacological evaluation of novel derivatives of L-beta-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3. |
AID1725872 | Selectivity index, ratio of IC50 for human EAAT2 transfected in mouse C17.2 cells to IC50 for human EAAT3 transfected in mouse C17.2 cells incubated for 5 mins by [3H]-D-aspartate uptake assay | 2020 | ACS medicinal chemistry letters, Nov-12, Volume: 11, Issue:11 ISSN: 1948-5875 | β-Indolyloxy Functionalized Aspartate Analogs as Inhibitors of the Excitatory Amino Acid Transporters (EAATs). |
AID1321948 | Inhibition of [3H]-D-Asp uptake at human EAAT1 expressed in HEK293 cells measured after 3 mins by TopCount method | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19 ISSN: 1520-4804 | β-Sulfonamido Functionalized Aspartate Analogues as Excitatory Amino Acid Transporter Inhibitors: Distinct Subtype Selectivity Profiles Arising from Subtle Structural Differences. |
AID1321949 | Inhibition of [3H]-D-Asp uptake at human EAAT2 expressed in HEK293 cells measured after 3 mins by TopCount method | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19 ISSN: 1520-4804 | β-Sulfonamido Functionalized Aspartate Analogues as Excitatory Amino Acid Transporter Inhibitors: Distinct Subtype Selectivity Profiles Arising from Subtle Structural Differences. |
AID1725870 | Inhibition of human EAAT3 transfected in mouse C17.2 cells assessed as inhibition of [3H]-D-aspartate uptake incubated for 5 mins by liquid scintillation counting analysis | 2020 | ACS medicinal chemistry letters, Nov-12, Volume: 11, Issue:11 ISSN: 1948-5875 | β-Indolyloxy Functionalized Aspartate Analogs as Inhibitors of the Excitatory Amino Acid Transporters (EAATs). |
AID1725869 | Inhibition of human EAAT2 transfected in mouse C17.2 cells assessed as inhibition of [3H]-D-aspartate uptake incubated for 5 mins by liquid scintillation counting analysis | 2020 | ACS medicinal chemistry letters, Nov-12, Volume: 11, Issue:11 ISSN: 1948-5875 | β-Indolyloxy Functionalized Aspartate Analogs as Inhibitors of the Excitatory Amino Acid Transporters (EAATs). |
AID1347050 | Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay | 2019 | Science translational medicine, 07-10, Volume: 11, Issue:500 ISSN: 1946-6242 | Inhibition of natriuretic peptide receptor 1 reduces itch in mice. |
AID1347058 | CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation | 2019 | PloS one, , Volume: 14, Issue:7 ISSN: 1932-6203 | Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors. |
AID1347049 | Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen | 2019 | Science translational medicine, 07-10, Volume: 11, Issue:500 ISSN: 1946-6242 | Inhibition of natriuretic peptide receptor 1 reduces itch in mice. |
AID1347405 | qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection | 2020 | ACS chemical biology, 07-17, Volume: 15, Issue:7 ISSN: 1554-8937 | High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle. |
AID1347057 | CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation | 2019 | PloS one, , Volume: 14, Issue:7 ISSN: 1932-6203 | Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors. |
AID1347151 | Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49 ISSN: 1091-6490 | Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
AID1508630 | Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay | 2021 | Cell reports, 04-27, Volume: 35, Issue:4 ISSN: 2211-1247 | A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. |
AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173ISSN: 1872-9096 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
AID1347045 | Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line | 2019 | Science translational medicine, 07-10, Volume: 11, Issue:500 ISSN: 1946-6242 | Inhibition of natriuretic peptide receptor 1 reduces itch in mice. |
AID588378 | qHTS for Inhibitors of ATXN expression: Validation | 2022 | The Journal of biological chemistry, 08, Volume: 298, Issue:8 ISSN: 1083-351X | |
AID1347410 | qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library | 2019 | Cellular signalling, 08, Volume: 60ISSN: 1873-3913 | A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening. |
AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173ISSN: 1872-9096 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
AID1347059 | CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation | 2019 | PloS one, , Volume: 14, Issue:7 ISSN: 1932-6203 | Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors. |
AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173ISSN: 1872-9096 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
AID588349 | qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay | 2022 | The Journal of biological chemistry, 08, Volume: 298, Issue:8 ISSN: 1083-351X | |
AID504836 | Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation | 2002 | The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16 ISSN: 0021-9258 | Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 ISSN: 1945-7170 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 ISSN: 1945-7170 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 ISSN: 1552-454X | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2022 | Journal of enzyme inhibition and medicinal chemistry, Dec, Volume: 37, Issue:1 ISSN: 1475-6374 | |
AID1346834 | Human Excitatory amino acid transporter 3 (Glutamate transporter subfamily) | 2005 | Neuropharmacology, Nov, Volume: 49, Issue:6 ISSN: 0028-3908 | The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3. |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (17.65) | 29.6817 |
2010's | 7 (41.18) | 24.3611 |
2020's | 7 (41.18) | 2.80 |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 17 (100.00%) | 84.16% |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
glutamic acid | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical | 2020 | 2020 | 4.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
2-amino-3-phenylmethoxybutanedioic acid | aspartic acid derivative | 2020 | 2020 | 4.0 | high | 0 | 0 | 0 | 0 | 1 | 0 | ||
dl-threo-beta-benzyloxyaspartate | 2008 | 2016 | 12.0 | high | 0 | 0 | 0 | 1 | 1 | 0 |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
aspartic acid | aspartate family amino acid; aspartic acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; mouse metabolite; neurotransmitter | 2005 | 2011 | 16.0 | high | 0 | 0 | 0 | 1 | 1 | 0 |
Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Congenital Zika Syndrome | 0 | 2020 | 2020 | 4.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
Contact Dermatitis | 0 | 2019 | 2019 | 5.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
Dermatitis, Contact | 0 | 2019 | 2019 | 5.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
Disease Models, Animal | 0 | 2019 | 2020 | 4.5 | medium | 0 | 0 | 0 | 0 | 2 | 0 | |
Itching | 0 | 2019 | 2019 | 5.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
Malaria, Falciparum | 0 | 2014 | 2014 | 10.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
Plasmodium falciparum Malaria | 0 | 2014 | 2014 | 10.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
Pruritus | 0 | 2019 | 2019 | 5.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
Zika Virus Infection | 0 | 2020 | 2020 | 4.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |